Bringing the fundamentals into focus…
Back to Beta Bionics, Inc.
How Beta Bionics, Inc. stacks up
BBNX · against 438 other Healthcare companies of similar size
Growth
93/ 100
Near the top of its peers.
Ranked #23 of 439 · scores higher than 94% of peers
Bars: peers in each 10-point band of the growth score35 peers with a growth score of 90–100, including BBNX · Click a bar to see the companies
Why growth scores 93?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 90% of peers. Revenue growth: 52.5% vs peer median 6.1%
- faster revenue growth over three years: stronger than 100% of peers. 3-year revenue growth: 724.3% vs peer median 5.8%
Metric by metric
Position: dot = BBNX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BBNX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 448 reported | 52.5% | 3.4% | 94% | 33% | |
| Earnings per share growthHigher is better · 242 reported | Not reported | 5.5% | — | — | 33% |
| 3-year revenue growthHigher is better · 434 reported | 724.3% | 4.6% | 100% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around BBNX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 16 | 467M USD | 95 | 44 | |
| 20 | 1.6B USD | 94 | 52 | |
| 20 | 20.8B THB (≈$581M) | 94 | 63 | |
| 20 | 884M USD | 94 | 75 | |
| 23 | 815M USD | 93 | 53 | |
| 23 | 1.5B USD | 93 | 32 | |
| 23 | 1.1B USD | 93 | 61 | |
| 23 | 871M USD | 93 | 53 | |
| 27 | 4.6B CNY (≈$639M) | 92 | 68 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score